Genpact Limited reports news on agentic and advanced technology solutions for enterprise operations, combining process intelligence, artificial intelligence, data capabilities and domain expertise. Company updates commonly cover quarterly results, Advanced Technology Solutions growth, Core Business Services, client operating-model transformation and management presentations at technology and investor conferences.
Recurring developments also include alliances and platform work with technology partners, including agentic AI solutions for finance workflows, ServiceNow consulting and implementation, web intelligence tools for regulated industries, and research on enterprise AI adoption. Genpact also announces capital-return actions such as quarterly cash dividends.
Genpact (NYSE: G) has been recognized as a leader in the Forrester Wave™: Insights-driven Business Process Outsourcing, Q4 2020 report. The firm received the highest scores in eight criteria, including vision and partner ecosystem. Forrester highlighted Genpact's capabilities in advanced analytics and automation, praising its ability to deliver insights as a service. Genpact's digital platform, Genpact Cora, along with strong client engagements, showcases its commitment to driving digital transformation for Global Fortune 500 companies.
Genpact (NYSE: G) will announce its first-quarter results for the period ending March 31, 2021, on May 10, 2021, after U.S. market close. Following this, a conference call will occur at 4:30 p.m. ET to discuss performance. Interested participants can dial in or join via a live webcast on Genpact's Investor Relations website. This earnings call is vital for investors seeking to understand Genpact's financial health and future outlook.
Genpact (NYSE: G) announced the appointment of Tamara Franklin, former Chief Digital, Data, and Analytics Officer at Marsh LLC, to its Board of Directors, effective March 29, 2021. Franklin's extensive experience in digital transformation and leadership roles at IBM and Scripps Networks Interactive is expected to enhance Genpact's strategic initiatives. Chairman Jim Madden and CEO Tiger Tyagarajan expressed optimism about her contributions, emphasizing her expertise in driving innovation and client experience.
On March 24, 2021, Genpact (NYSE: G), alongside the Creative Destruction Lab Rapid Screening Consortium and the COVID Collaborative, launched the U.S. Rapid Action Consortium. This initiative aims to fast-track safe, cost-effective COVID-19 testing to facilitate business reopenings. The Consortium publicizes its findings and testing protocols to support workplaces across the U.S., inspired by a successful Canadian model. The first cohort of participating companies is set to commence on April 5, 2021, amid rising urgency for systematic rapid testing as the economy faces significant losses.
Genpact Limited (NYSE: G) announced a $350 million public offering of 1.750% senior notes due 2026, priced by its subsidiaries, Genpact Luxembourg and Genpact USA. The offering is expected to close on March 26, 2021, pending customary conditions. The proceeds may be used for general corporate purposes, including repaying existing debt. The offering is part of an effective shelf registration with the SEC. Genpact emphasizes its commitment to digital transformation and innovation across its operations, serving numerous Global Fortune 500 clients.
Commonwealth Informatics, a subsidiary of Genpact, launched an upgraded version of its Commonwealth Vigilance Workbench (CVW) on March 22, 2021. This cloud-based solution aims to enhance drug safety through advanced AI and analytics, benefiting life sciences and regulatory agencies. Two major global pharmaceutical companies have implemented the new CVW, which streamlines signal detection and management of adverse drug effects. The latest enhancements improve data review, signal tracking, and report generation. Commonwealth's focus on pharmacovigilance is timely, given the ongoing COVID-19 pandemic.
Genpact (NYSE:G) has secured two patents from the U.S. Patent and Trademark Office for innovative business transformation frameworks: Genpact ProcIndex and Intelligent Automation Index. ProcIndex measures process health using analytics, helping companies identify improvement opportunities, while the Intelligent Automation Index assesses automation potential across processes. By leveraging these tools, Genpact enables firms to drive operational efficiency and optimize ROI. Both frameworks have been successfully implemented by over 100 clients, leading to significant improvements in process efficiency and cost reduction.
Genpact (NYSE: G) has announced an extension of its strategic partnership with Envision Virgin Racing, focusing on digital transformation through 2022. This collaboration aims to enhance the racing team's performance both on and off the track, leveraging data analytics for real-time decision-making. Since 2018, they have co-innovated to reduce climate impact and engage a sustainability-focused fanbase. The partnership emphasizes not just competitive advantage on the racetrack but also a commitment to combating climate change, representing Genpact's role in advancing sustainable practices.
Summary not available.
Summary not available.